Dr. Lal PathLabs Limited (LALPATHLAB.BO) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,028.95

Open2,050.00

Day range1,944.002,050.00

52-week range1,272.002,050.00

Off day high−3.98%

Off 52-week high−3.98%

Volume154.80K

Avg. volume (3M)15.75K

Market cap329.14B

EPS (TTM)34.87

Forward P/E44.86

P/E ratio (TTM)56.45

Dividend yield0.99% (20.00)

Beta (5Y)0.20

Shares outstanding167.21M

Short interest—

Earnings dateNov 4, 2026 (est.)

Analyst target2,018.08

Profit margin18.75%

Against its peers

Compare in full ›

	LALPATHLAB.BO	4694.T	4544.T	LH	METROPOLIS.BO	DGNS.JK
Market cap	329.14B	147.12B	217.00B	29.86B	118.56B	401.50B
P/E (TTM)	56.4	18.8	23.5	30.1	53.0	5.6
Forward P/E	44.9	26.4	39.3	18.8	36.8	—
Price/book	12.0	1.2	1.6	3.4	7.2	1.8
Dividend yield	0.99%	3.30%	3.22%	0.78%	0.34%	—
1-year change	+30.27%	+3.55%	−0.56%	+49.12%	+15.88%	+98.59%
Today	−2.98%	+3.56%	+3.51%	+3.92%	−1.85%	+3.55%

The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Dr. Lal PathLabs's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
BML, Inc.4694.T · Diagnostics & Research	147.12B	3,925.00	+3.56%
H.U. Group Holdings, Inc.4544.T · Diagnostics & Research	217.00B	4,015.00	+3.51%
Labcorp Holdings Inc.LH · Diagnostics & Research	29.86B	367.79	+3.92%
Metropolis Healthcare LimitedMETROPOLIS.BO · Diagnostics & Research	118.56B	571.30	−1.85%
PT Diagnos Laboratorium Utama TbkDGNS.JK · Diagnostics & Research	401.50B	292.00	+3.55%
Vijaya Diagnostic Centre LimitedVIJAYA.NS · Diagnostics & Research	148.08B	1,437.70	+0.92%
Joinn Laboratories(China)Co.,Ltd.603127.SS · Diagnostics & Research	34.88B	46.55	+5.56%
Noul Co.,Ltd.376930.KQ · Diagnostics & Research	13.55B	1,321.00	−0.08%

Other companies in Diagnostics & Research, closest in size first.

Company	Mkt cap	Price	Today
Sai Life Sciences LimitedSAILIFE.NS · Hyderabad, India	338.79B	1,594.50	+3.13%
PT Diagnos Laboratorium Utama TbkDGNS.JK · Jakarta Pusat, Indonesia	401.50B	292.00	+3.55%
Thermo Fisher Scientific Inc.TMO · Waltham, MA	261.64B	706.16	+1.12%
H.U. Group Holdings, Inc.4544.T · Tokyo, Japan	217.00B	4,015.00	+3.51%
WuXi AppTec Co., Ltd.2359.HK · Shanghai, China	620.33B	204.400	+3.34%
Syngene International LimitedSYNGENE.BO · Bengaluru, India	166.51B	414.30	−0.70%
Danaher CorporationDHR · Washington, DC	165.15B	234.93	+2.09%
Vijaya Diagnostic Centre LimitedVIJAYA.NS · Hyderabad, India	148.08B	1,437.70	+0.92%

Healthcare companies of a similar market value (318.75B).

Company	Mkt cap	Price	Today
Piramal Pharma LimitedPPLPHARMA.NS · Drug Manufacturers - Specialty & Generic	316.44B	238.63	+0.37%
Japan Vietnam Medical Investment and Development Joint Stock CompanyJVC.VN · Medical Devices	321.75B	2,860.00	+2.14%
Roche Holding AGROP.SW · Drug Manufacturers - General	313.69B	393.70	−0.56%
BeOne Medicines AG6160.HK · Biotechnology	367.68B	248.600	+7.34%
Bangkok Dusit Medical Services Public Company LimitedBDMS.BK · Medical Care Facilities	319.43B	20.10	+1.52%
Sai Life Sciences LimitedSAILIFE.NS · Diagnostics & Research	338.79B	1,594.50	+3.13%
argenx SEA1RG34.SA · Biotechnology	317.26B	201.80	+3.66%
Wockhardt LimitedWOCKPHARMA.BO · Drug Manufacturers - Specialty & Generic	323.45B	1,990.30	+4.76%

Also based in Gurugram, India, then elsewhere in India.

Company	Mkt cap	Price	Today
Bharti Airtel LimitedBHARTIARTL.NS · Gurugram, India	12.83T	2,056.90	−0.52%
Eternal LimitedETERNAL.NS · Gurugram, India	3.30T	358.30	+4.01%
Power Grid Corporation of India LimitedPOWERGRID.BO · Gurugram, India	2.43T	261.00	−0.38%
Nestlé India LimitedNESTLEIND.NS · Gurugram, India	2.43T	1,258.30	+0.83%
InterGlobe Aviation LimitedINDIGO.BO · Gurugram, India	2.10T	5,438.00	+5.80%
DLF LimitedDLF.BO · Gurugram, India	1.84T	745.00	+3.58%
Hyundai Motor India LimitedHYUNDAI.NS · Gurugram, India	1.72T	2,121.00	+2.81%
Varun Beverages LimitedVBL.BO · Gurugram, India	1.46T	432.20	+3.02%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All LALPATHLAB.BO news ›

SAHI·15h agoPositive

Dr Lal PathLabs Reports Q2 Consolidated Net Profit Of ₹1.9 Billion

Dr. Lal PathLabs posted Q2 consolidated net profit of ₹192 crore compared to ₹151 crore a year earlier. Operating revenue rose to ₹874 crore on the back of 13.6% sample volume growth. Operating EBITDA stood at ₹280 crore with margins at…

SRN News·19h agoPositive

India's Dr Lal PathLabs posts higher quarterly profit on strong diagnostic test demand

Nov 4 (Reuters) – Dr Lal PathLabs posted a more than 27% rise in second-quarter profit on Wednesday, helped by higher test volumes and demand for preventive health packages. The Indian lab operator’s consolidated net profit for the three…

News18·1d agoPositive

Dr Lal PathLabs Q2 net profit jumps 27 pc to Rs 194 cr

New Delhi, Nov 4 (PTI) Dr Lal PathLabs on Wednesday said its consolidated profit after tax (PAT) increased 27.39 per cent to Rs 193.9 crore for the September quarter on the back of a rise in revenues. The diagnostics firm reported a profit…

Multibagg AI·1d agoPositive

Dr. Lal PathLabs Limited Set to Consider Q2 FY27 Results

Dr. Lal PathLabs Limited is scheduled to consider its unaudited Q2 FY27 results for the quarter ended 30 September 2026 on 4 November, following Q1 revenue growth of 19.1% year-on-year to ₹797.70 crore. The board will also consider a…

Business Upturn·1d agoPositive

Sensex, Nifty Today LIVE: NSE Stock Market Updates, Nov 4, 2026: Jupiter Wagons wins ₹61 crore Balmer Lawrie order | Dr. Lal PathLabs H1 FY27 revenue: ₹1,672 crore

Jupiter Wagons Limited secures an order worth ₹61 crore from Balmer Lawrie for railway rakes and a brake van. Dr. Lal PathLabs achieves ₹1,672 crore revenue for H1 FY27, marking robust growth with increased patient volumes and operational…

INFY

Udaipur Kiran·Oct 14·2 outletsPositive

Dr. Lal Pathlabs rises as its arm acquires remaining 30% stake in Centrapath Labs

Mumbai, October 14 (Udaipur Kiran): Dr. Lal Pathlabs is currently trading at Rs. 1928.20, up by 16.70 points or 0.87% from its previous closing of Rs. 1911.50 on the BSE. The scrip opened at Rs. 1909.00 and has touched a high and low of…

Axis Direct bullish on Dr Lal PathLabs, Vijaya Diagnostic and Nephrocare, assigns 'Buy' ratings with up to 21% upside

Axis Direct is bullish on Dr Lal PathLabs, Vijaya Diagnostic Centre and Nephrocare Health Services, assigning 'Buy' ratings to all three stocks and setting target prices that imply an upside of up to 21%, citing structural growth drivers…

Free Press Journal·Oct 12·2 outlets

Dr. Lal PathLabs Invests Up To ₹30.3 Crore In Wholly Owned Subsidiary PUPL

Dr. Lal PathLabs has made a further investment of up to ₹30.3 crore in its wholly owned subsidiary, PathLabs Unifiers Private Limited (PUPL). The investment involves a cash consideration not exceeding ₹30.3 crore. PUPL will continue to…

LH

Income Tax Dept. appeals against tax relief favouring Dr Lal PathLabs; stock falls 2.4%

Dr Lal PathLabs said the Income Tax Department has appealed to the ITAT against an earlier order granting the company relief on ₹32.66 crore in ESOP expenses for assessment year 2022-23. Dr Lal PathLabs Limited disclosed on Thursday that…

From the 4Search news index, newest first.

In the news

15mentions in 30 days

15with it in the headline

Positivesentiment

Most coverage from

businessupturn.com2
thehindubusinessline.com2
tradingview.com2
freedom959.net1
freepressjournal.in1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 15 articles, not a forecast.

Key statistics

Against its peers

Related companies

Latest news

In the news

Mentioned with

People in the coverage

Themes

Most coverage from